TP53 and non-small cell lung carcinoma: For instance, TCGA database reported the highest frequency of TP53 mutations in uterine cancer (90%), followed by 83% of mutations in NSCLC, ovarian, and esophageal cancer, 80% in colorectal cancer, and 72% in HNSCC.